ArticlePathology oncology research : POR2022

Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry.

Ferenc Takács et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.